Yakup Ergün

457 total citations
44 papers, 181 citations indexed

About

Yakup Ergün is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yakup Ergün has authored 44 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Yakup Ergün's work include Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (8 papers) and Cancer Treatment and Pharmacology (7 papers). Yakup Ergün is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (8 papers) and Cancer Treatment and Pharmacology (7 papers). Yakup Ergün collaborates with scholars based in Türkiye, United Kingdom and United States. Yakup Ergün's co-authors include Gökhan Uçar, Baran Akagündüz, Doğan Uncu, Öznur Bal, Cengiz Karaçin, Nuriye Özdemir, Mutlu Doğan, Berna Öksüzoğlu, Ozan Yazıcı and Mehmet Alı Nahıt Şendur and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yakup Ergün

32 papers receiving 178 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yakup Ergün Türkiye 7 122 62 58 30 24 44 181
Silvana Acquafredda Italy 6 159 1.3× 40 0.6× 94 1.6× 42 1.4× 24 1.0× 8 237
Ina Valeria Zurlo Italy 6 105 0.9× 40 0.6× 89 1.5× 36 1.2× 42 1.8× 24 191
Zorka Inić Serbia 5 92 0.8× 69 1.1× 29 0.5× 55 1.8× 18 0.8× 16 183
László Landherr Hungary 8 122 1.0× 61 1.0× 62 1.1× 42 1.4× 11 0.5× 20 191
Carole Massabeau France 9 68 0.6× 78 1.3× 56 1.0× 30 1.0× 28 1.2× 32 196
Sanjeev Deva New Zealand 9 179 1.5× 29 0.5× 60 1.0× 64 2.1× 20 0.8× 37 249
Uriel Bohn Spain 9 144 1.2× 68 1.1× 85 1.5× 33 1.1× 16 0.7× 16 253
Maria Passhak Israel 6 153 1.3× 25 0.4× 51 0.9× 16 0.5× 25 1.0× 9 182
David Vicente Baz Spain 10 173 1.4× 29 0.5× 138 2.4× 52 1.7× 17 0.7× 27 235
Mei Xie China 11 100 0.8× 65 1.0× 99 1.7× 93 3.1× 27 1.1× 28 251

Countries citing papers authored by Yakup Ergün

Since Specialization
Citations

This map shows the geographic impact of Yakup Ergün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yakup Ergün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yakup Ergün more than expected).

Fields of papers citing papers by Yakup Ergün

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yakup Ergün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yakup Ergün. The network helps show where Yakup Ergün may publish in the future.

Co-authorship network of co-authors of Yakup Ergün

This figure shows the co-authorship network connecting the top 25 collaborators of Yakup Ergün. A scholar is included among the top collaborators of Yakup Ergün based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yakup Ergün. Yakup Ergün is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Poyrazoğlu, Orhan Kürşat, et al.. (2025). Novel tumor marker index combining carcinoembryonic antigen and carbohydrate antigen 19-9: New prognostic factor for metastatic colorectal cancer. World Journal of Gastrointestinal Oncology. 17(5). 104341–104341.
3.
Ergün, Yakup. (2025). HER3 in breast cancer: molecular insights, clinical implications, and therapeutic horizons. Expert Opinion on Therapeutic Targets. 29(7). 481–489.
4.
Karaçin, Cengiz, Zuhat Urakçı, Ali Yılmaz, et al.. (2024). Efficacy and Safety of Bevacizumab in Patients with Low-Grade Serous Ovarian Cancer. Future Oncology. 20(4). 207–214.
5.
Avcı, Nilüfer, Ali Alkan, Yakup Ergün, et al.. (2024). Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment. Scientific Reports. 14(1). 10632–10632.
6.
7.
Ergün, Yakup, Gökhan Uçar, & Baran Akagündüz. (2023). Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis. Cancer Treatment Reviews. 115. 102538–102538. 35 indexed citations
8.
9.
Ergün, Yakup, et al.. (2023). Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data. Cancer Management and Research. Volume 15. 1085–1096.
10.
Ma, Kaplan, Mevlüde İnanç, Doğan Uncu, et al.. (2022). The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients. Pancreas. 51(9). 1153–1159. 1 indexed citations
11.
Uçar, Gökhan, et al.. (2021). The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer. Cureus. 13(5). e14882–e14882. 4 indexed citations
12.
Karaçin, Cengiz, Yakup Ergün, & Berna Öksüzoğlu. (2021). Saying goodbye to primary endocrine resistance for advanced breast cancer?. Medical Oncology. 38(1). 5–5. 3 indexed citations
13.
Karaçin, Cengiz, et al.. (2021). Tamoxifen in breast cancer survivors with COVID 19: stop or go?. Medical Oncology. 38(4). 42–42. 1 indexed citations
14.
Bal, Öznur, et al.. (2020). Systemic treatment options for growing teratoma syndrome. Journal of Cancer Research and Therapeutics. 17(1). 75–79.
15.
Uçar, Gökhan, Yakup Ergün, Öznur Bal, et al.. (2020). Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma?. Cureus. 12(9). e10525–e10525. 5 indexed citations
16.
Sakin, Abdullah, et al.. (2020). The Real-Life Data of BRAF Mutation on the Treatment of Colorectal Cancer: a TOG Study. Journal of Gastrointestinal Cancer. 52(3). 932–939. 1 indexed citations
17.
Uçar, Gökhan, et al.. (2020). Prognostic and Predictive Value of NAR Score in Gastric Cancer. Journal of Gastrointestinal Cancer. 52(3). 1054–1060. 1 indexed citations
18.
Uçar, Gökhan, et al.. (2020). The effect of chemotherapy on olfactory function and mucociliary clearance. Supportive Care in Cancer. 29(3). 1635–1641. 4 indexed citations
19.
Ergün, Yakup, et al.. (2020). Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?. Journal of Research in Medical Sciences. 25(1). 14–14. 12 indexed citations
20.
Ergün, Yakup, Öznur Bal, Mutlu Doğan, & Doğan Uncu. (2020). Capecitabine plus temozolomide (CapTem): An alternative regimen to regorafenib as third-line setting in metastatic colorectal cancer?. PubMed. 24(6). 2435–2441. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvana Acquafredda Breakdown of academic impact, for papers by Ina Valeria Zurlo Breakdown of academic impact, for papers by Zorka Inić Breakdown of academic impact, for papers by László Landherr Breakdown of academic impact, for papers by Carole Massabeau Breakdown of academic impact, for papers by Sanjeev Deva Breakdown of academic impact, for papers by Uriel Bohn Breakdown of academic impact, for papers by Maria Passhak Breakdown of academic impact, for papers by David Vicente Baz Breakdown of academic impact, for papers by Mei Xie
Rankless by CCL
2026